Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for AQB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 8.897M
March 31, 2026 12.38M
December 31, 2025 12.23M
September 30, 2025 11.93M
June 30, 2025 13.04M
March 31, 2025 12.46M
September 30, 2024 17.71M
June 30, 2024 24.09M
March 31, 2024 22.34M
December 31, 2023 22.53M
September 30, 2023 19.36M
June 30, 2023 30.87M
March 31, 2023 20.65M
December 31, 2022 21.92M
September 30, 2022 24.88M
June 30, 2022 16.73M
March 31, 2022 12.78M
December 31, 2021 14.63M
September 30, 2021 11.56M
June 30, 2021 11.57M
March 31, 2021 10.89M
December 31, 2020 10.90M
September 30, 2020 11.06M
June 30, 2020 6.713M
March 31, 2020 6.418M
Date Value
December 31, 2019 6.473M
September 30, 2019 6.079M
June 30, 2019 7.056M
March 31, 2019 5.474M
December 31, 2018 4.437M
September 30, 2018 4.514M
June 30, 2018 4.160M
March 31, 2018 5.154M
December 31, 2017 5.751M
September 30, 2017 4.718M
June 30, 2017 3.955M
March 31, 2017 3.590M
December 31, 2016 3.681M
September 30, 2016 11.19M
June 30, 2016 8.029M
March 31, 2016
December 31, 2015 2.692M
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014 3.099M
September 30, 2014 3.402M
June 30, 2014 3.367M
March 31, 2014 3.037M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 436.29M
Agenus, Inc. 378.54M
Alnylam Pharmaceuticals, Inc. 4.205B
Amgen, Inc. 83.95B
Anika Therapeutics, Inc. 46.19M

Total Liabilities (Quarterly) Related Metrics